“oral”的搜索结果，显示 101-110 项，共有 4155 项

1. 复合避孕药- 妙佑医疗国际

   Hatcher RA, et al., eds. Combined oral contraceptives (COCs). In: Contraceptive Technology. 21st ed. Ayer Company Publishers; 2018. American College of ...

2. 放射科- 临床试验- 妙佑医疗国际

   ... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...

3. 蛀牙和龋齿- 诊断与治疗- 妙佑医疗国际

   O'Connor FG, et al. Oral and systemic health. https://www.uptodate.com/contents/search. Accessed Nov. 6, 2023. Salli K, et al. Xylitol's health benefits ...

4. 口干- 诊断与治疗- 妙佑医疗国际

   Xerostomia. Oral Cancer Foundation. https://oralcancerfoundation.org/complications/xerostomia/. Accessed Nov. 21, 2023. Xerostomia (dry mouth). American ...

5. 颚部手术- 在 Mayo Clinic 治疗 - 妙佑医疗国际

   American Association of Oral and Maxillofacial Surgeons. https://aaoms.org/publications/position-papers/clinical-papers. Accessed Nov. 11, 2024. Baker SB ...

6. 过敏科- 临床试验- 妙佑医疗国际

   ... oral corticosteroids, topical corticosteroids, leukotriene receptor ... The purpose of this study is to compare change in SNOT-22 score in patients who received ...

7. 舌系带过短（舌黏连） - 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生. Jonathan Fillmore, M.D., D.M.D.. Oral and Maxillofacial Surgeon.

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

9. 肺癌计划- 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. Patients will ...

10. 避孕药常见问题：好处、风险和选择

    Oral contraceptives and cancer risk. National Cancer Institute. https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/oral-contraceptives-fact ...